Home Title Index Topic Index Sources Directory News Releases Sources Calendar RSS Sources Select News RSS Feed

Alzheimer’s Weekly names ANAVEX 2-73 the number one most promising trial drug in Alzheimer's disease and Anavex’s Phase I clinical program as "Trial
Sources News Release

http://www.sources.com/Releases/NR1118.htm

Publisher:  Dr. Cameron Durrant, MD, MBA, Alzheimer's Disease and Pharmaceuticals/Biot
Date Written:  11/01/2011
Year Published:  2011  
Resource Type:  Article

ANAVEX 2-73 has been named 2010’s “most promising trial drug” by the editorial staff at Alzheimer’s Weekly.

Abstract:  Hoboken, NJ – January 6, 2011 - Anavex Life Sciences Corp. (“Anavex”, AVXL.OB) announced today that ANAVEX 2-73 has been named 2010’s “most promising trial drug” by the editorial staff at Alzheimer’s Weekly. The publication selected the ANAVEX 2-73 trial from a field of over 100 trials that treat dementias such as Alzheimer’s and following the review of more than 10,000 articles. Staffers and clinical experts of Alzheimer’s Weekly said that Anavex stands out when scrutinized against their key cr...
To read the full release go to http://www.sources.com/Releases/NR1118.htm

Topics


Sources-journalists use the sources website to find you


AlterLinks
c/o Sources


© 2018. The information provided is copyright and may not be reproduced in any form or by any means (whether electronic, mechanical or photographic), or stored in an electronic retrieval system, without written permission of the publisher. The content may not be resold, republished, or redistributed. Indexing and search applications by Ulli Diemer and Chris DeFreitas.